Medeon Biodesign (ROCO:6499) Ending Cash Position : NT$1,265.2 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Ending Cash Position?

Medeon Biodesign's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$1,265.2 Mil.

Medeon Biodesign's quarterly Ending Cash Position declined from Jun. 2023 (NT$1,927.9 Mil) to Sep. 2023 (NT$1,471.3 Mil) and declined from Sep. 2023 (NT$1,471.3 Mil) to Mar. 2024 (NT$1,265.2 Mil).

Medeon Biodesign's annual Ending Cash Position declined from Dec. 2020 (NT$1,128.1 Mil) to Dec. 2021 (NT$735.3 Mil) and declined from Dec. 2021 (NT$735.3 Mil) to Dec. 2022 (NT$483.9 Mil).

Medeon Biodesign Ending Cash Position Historical Data

The historical data trend for Medeon Biodesign's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Ending Cash Position Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

328.11

472.06

1,128.13

735.32

483.90

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															483.90	691.46	1,927.88	1,471.30	1,265.25

Medeon Biodesign Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medeon Biodesign's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	735.32	+	-251.422
	=	483.9

Medeon Biodesign's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1237.964	+	27.281
	=	1,265.2

Medeon Biodesign Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines